Phospholipid metabolism in Leishmania
Description: Leishmania parasites cause 0.7-1.3 million new cases and 50000-90000 deaths each year. Current treatments are inadequate and more research on Leishmania biology is needed to develop new drugs. The goal of this AREA grant is to better understand lipid metabolism in Leishmania and provide rigorous biomedical research training to undergraduate and graduate students at Texas Tech University.
Funding type: research
Funder scheme: R15
Start date: 2021-09-01
End date: 2027-08-31
Investigator: KAI ZHANG
Institution: TEXAS TECH UNIVERSITY
Field: Medicine
Domain: Health Sciences
Funded outputs count: 7
Funder award ID: R15AI156746
OpenAlex ID: G577334394
